We serve Chemical Name:Benzo[d]isoxazol-3-ol CAS:21725-69-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![Benzo[d]isoxazol-3-ol](https://a.dearchem.com/CAS2/21725-69-9.png)
Chemical Name:Benzo[d]isoxazol-3-ol
CAS.NO:21725-69-9
Synonyms:3-Hydroxybenzisoxazole;1,2-Benzisoxazol-3(2H)-one;3-Hydroxy-1,2-benzisoxazole;1,2-benzisoxazol-3-ol;1,2-Benzisoxazol-3-ol 1,2-Benzisoxazolin-3-one 3-Hydroxy-1,2-benzisoxazole Benzo[d]isoxazol-3-ol;Benzo[d]isoxazol-3-ol;1,2-benzoxazol-3-ol;1,2-Benzoxazol-3(2H)-one;MFCD00125030;1,2-Benzisoxazolin-3-one
Molecular Formula:C7H5NO2
Molecular Weight:135.120
HS Code:2934999090
Physical and Chemical Properties:
Melting point:140-142ºC
Boiling point:299.9±13.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.664
PSA:46.26000
Exact Mass:135.032028
LogP:0.89
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Hydroxybenzisoxazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-Benzisoxazolin-3-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzo[d]isoxazol-3-ol Use and application,MFCD00125030 technical grade,usp/ep/jp grade.
Related News: Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). Sumiresin PR 50235,6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate4-methylbenzenesulfonate manufacturers The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet. 4-Brom-2-methyl-2-phenyl-pentan suppliers In taking control of Vanamali, Wavelength will double the firm’s production capacity and add more than 10 key regulatory starting materials and drug intermediates for Wavelength’s own strategic APIs and API CDMO customers, a Wavelength spokeswoman said by email. α-[p-(1-cyclohexenyl)-phenoxy]-decanoic acid ethyl ester vendor & factory.
